Sanofi (South Korea)

Recent papers from Sanofi (South Korea)

1. Exacerbation-related burden in patients with severe asthma in South Korea: a population-based cohort studyBMJ Open Respiratory Research · 2026
2. Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in KoreaHuman Vaccines & Immunotherapeutics · 2025
3. Synthesis of (E)-3-(aryl)-1-phenylprop-2-en-1-one Chalcone Derivatives for Hyperglycemic Effect in Diabetes: In Vitro, In Vivo and In Silico ApproachCurrent Medicinal Chemistry · 2025
4. Disease Burden of Respiratory Syncytial Virus in Korean Children: A Nationwide Cohort StudyThe Pediatric Infectious Disease Journal · 2025
5. Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean studyJournal of Diabetes and its Complications · 2025
6. Trends in Proportions of Respiratory Syncytial Virus Infections Among Reported Respiratory Tract Infection Cases in Children Aged 0 to 5 Years in Western Pacific and Southeast Asia Regions: A Systematic Review and Meta‐AnalysisInfluenza and Other Respiratory Viruses · 2025
7. Current Status of Lipid Management and Subsequent Cardiovascular Events After Acute Coronary Syndrome in Korea: Real-World Findings From Observational and Survey StudiesJournal of Cardiovascular Intervention · 2025
8. RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging OptionsInfection and Chemotherapy · 2024
9. Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean dataHealth Economics Review · 2024
10. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE StudyAdvances in Therapy · 2024
11. Enhancing Diabetes Care through a Mobile Application: A Randomized Clinical Trial on Integrating Physical and Mental Health among Disadvantaged IndividualsDiabetes & Metabolism Journal · 2024
12. Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE TrialAllergy Asthma and Immunology Research · 2024
13. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rateOpen Forum Infectious Diseases · 2023
14. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rateHuman Vaccines & Immunotherapeutics · 2023
15. Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South KoreaInfectious Diseases and Therapy · 2023
16. Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South KoreaInfectious Diseases and Therapy · 2022
17. Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015Infectious Diseases and Therapy · 2022
18. Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in KoreaDiabetes Metabolic Syndrome and Obesity · 2022
19. Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South KoreaAnnals of Dermatology · 2022
20. Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in KoreaJournal of Obesity & Metabolic Syndrome · 2021